Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic Cancer

NCT07645651 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Resectable Pancreatic Ductal Adenocarcinoma
Borderline Resectable Pancreatic Ductal Adenocarcinoma
Locally Advanced Pancreatic Ductal Adenocarcinoma

Interventions

DRUG: Samuraciclib
PROCEDURE: Computed Tomography
PROCEDURE: Endoscopic Ultrasound Biopsy
PROCEDURE: Biospecimen Collection

Sponsor

University of Washington

Collaborators

[object Object]
[object Object]
[object Object]